Structure Therapeutics Email Format
Biotechnology ResearchCalifornia, United States201-500 Employees
Structure Therapeutics is a mid-sized biotechnology company based in South San Francisco, California. It concentrates on discovering and developing oral small molecule therapies for chronic metabolic and cardiopulmonary diseases with significant unmet medical needs. The company uses a next generation structure-based drug discovery platform to advance a GPCR-focused pipeline of wholly owned, clinical-stage compounds. Its approach aims to overcome the scalability limitations of biologics and peptides, seeking to make therapies more accessible to patients worldwide. In 2025, the company appointed Matthew Lang as Chief Operating Officer and General Counsel, marking a notable leadership development alongside its ongoing clinical programs.